Anorit Medical

Cardiac Arrest out-of-hospital affects more than 350.000 people every year in Europe alone. Survival depends on the prompt response of bystanders and the provision of Basic Life Support. 

We, at Anorit Medical, are pioneering an innovative ventilation device, with the potential to raise survival rates during out-of-hospital cardiac arrests. Our device allows laypersons to provide high quality air in a simple way and without direct contact with the patient.

Our team was initially formed while attending the BioMedical Design Novo Nordisk Foundation Fellowship Programme. During the programme, our team was created with a focus on diversity in terms of skills, backgrounds and experience. Andreas Konradsen, Minik Nørreslet and Sotiria Athanasiadou, together with the fourth member of our team – Nanna Skytt Pilmark, doctor and PhD – worked together at identifying a real need within healthcare and then taking the first steps to develop a solution for it. 

The main available option for laypersons is mouth-to-mouth ventilation. This technique poses an intimacy barrier due to the direct contact with the patient, discouraging laypersons to perform it. Additionally, it is a complex task, so even when mouth-to-mouth ventilation is performed, the success rate is low. 

Our innovative device addresses this problem by eliminating the need for direct contact, simplifying the task, and providing high quality of air. All the while not interfering with the essential tasks of chest compressions and shock via AEDs. 

We believe that our different backgrounds have allowed us to combine diverse understandings of healthcare, systems, resources and social structures, as well as to leverage a strong international network.